Medicare Enrolled

Dr. Jason Ignatius, DO

Neurology · Du Bois, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
145 HOSPITAL AVE, Du Bois, PA 15801
8143752070
In practice since 2009 (17 years)
NPI: 1447485263 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ignatius from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ignatius? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ignatius

Dr. Jason Ignatius is a neurology specialist in Du Bois, PA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Ignatius performed 653 Medicare services across 520 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ignatius received a total of $220,933 from 60 pharmaceutical and/or device companies across 1634 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ignatius is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 21% volume in PA $220,933 industry payments

Medicare Practice Summary

Medicare Utilization ↗
653
Medicare services
Top 21% in PA for neurology
520
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~38 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
346 $67 $100
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
78 $103 $146
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
62 $95 $136
New patient office visit, complex (60-74 min) 46 $127 $184
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
42 $44 $115
Injection of anesthetic or steroid into upper neck and back of head nerve
An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head.
32 $54 $286
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
25 $48 $68
EEG brain wave test, 61-119 minutes
This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes.
11 $66 $183
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
11 $44 $115
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$220,933
Total received (2018-2024)
Avg $31,562/year across 7 years
Top 5% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
1,634
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$205,256 (92.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,677 (7.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,954
2023
$9,091
2022
$30,099
2021
$59,458
2020
$42,055
2019
$53,709
2018
$22,567

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$849
MDD US Operations, LLC
$312
UCB, Inc.
$271
ABBVIE INC.
$226
PFIZER INC.
$225
Biogen, Inc.
$225
Amneal Pharmaceuticals LLC
$200
Lundbeck LLC
$189
ARGENX US, INC.
$170
Genentech USA, Inc.
$170
Celgene Corporation
$160
Neurocrine Biosciences, Inc.
$136
Lilly USA, LLC
$117
TG Therapeutics, Inc.
$103
Neurelis, Inc.
$83
ACADIA Pharmaceuticals Inc
$76
Mallinckrodt Hospital Products Inc.
$73
HARMONY BIOSCIENCES LLC
$59
JAZZ PHARMACEUTICALS INC.
$57
MITSUBISHI TANABE PHARMA AMERICA, INC.
$50
Otsuka America Pharmaceutical, Inc.
$44
Kyowa Kirin, Inc.
$44
Eisai Inc.
$40
LivaNova USA, Inc.
$38
Amgen Inc.
$20
Aucta Pharmaceuticals, Inc.
$17
Top 3 companies account for 36.2% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$87,453
Amgen Inc.
$31,414
ABBVIE INC.
$24,329
AbbVie Inc.
$23,639
Allergan, Inc.
$20,022
Lilly USA, LLC
$9,305
Biohaven Pharmaceuticals, Inc.
$6,585
Biohaven Pharmaceutical Holding Company Ltd.
$3,819
Adamas Pharmaceuticals, Inc.
$2,643
Biogen, Inc.
$1,798
UCB, Inc.
$1,127
Genentech USA, Inc.
$755
Lundbeck LLC
$622
PFIZER INC.
$546
Alexion Pharmaceuticals, Inc.
$545
Novartis Pharmaceuticals Corporation
$508
Neurelis, Inc.
$434
Amneal Pharmaceuticals LLC
$368
Celgene Corporation
$366
MDD US Operations, LLC
$343
GENZYME CORPORATION
$338
Neurocrine Biosciences, Inc.
$324
ARGENX US, INC.
$312
LivaNova USA, Inc.
$258
EMD Serono, Inc.
$237
Sunovion Pharmaceuticals Inc.
$232
ACADIA Pharmaceuticals Inc
$191
Allergan Inc.
$188
Harmony Biosciences LLC
$171
Kyowa Kirin, Inc.
$167
Otsuka America Pharmaceutical, Inc.
$163
MITSUBISHI TANABE PHARMA AMERICA, INC.
$147
Acorda Therapeutics, Inc
$123
Abbott Laboratories
$118
JAZZ PHARMACEUTICALS INC.
$113
Eisai Inc.
$106
TG Therapeutics, Inc.
$103
CSL Behring
$100
E.R. Squibb & Sons, L.L.C.
$94
HARMONY BIOSCIENCES LLC
$79
Greenwich Biosciences, Inc.
$76
Mallinckrodt Hospital Products Inc.
$73
EISAI INC.
$73
Banner Life Sciences, LLC
$66
Upsher-Smith Laboratories LLC
$65
Supernus Pharmaceuticals, Inc.
$64
Impax Laboratories, Inc.
$48
Strongbridge US INC.
$38
Avanir Pharmaceuticals, Inc.
$35
SK Life Science, Inc.
$32
Mallinckrodt LLC
$29
AbbVie, Inc.
$21
Akcea Therapeutics, Inc.
$20
Mallinckrodt Enterprises LLC
$19
Aucta Pharmaceuticals, Inc.
$17
US WorldMeds, LLC
$16
Promius Pharma LLC
$16
Grifols USA, LLC
$15
Janssen Pharmaceuticals, Inc
$14
IMPEL PHARMACEUTICALS INC.
$12
Top 3 companies account for 64.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · COPAXONE · CREXONT · DUOPA · Duopa · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Hizentra · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · Kcentra · LATUDA · LEMTRADA · Leqembi · MAYZENT · Mavenclad · Motpoly XR · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · Ocrevus · Ocrevus Zunovo · Ongentys · POMPE - DISEASE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · SOLIRIS · SPINRAZA · SUNOSI · Soliris · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XARELTO · ZEPOSIA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for neurology in PA.

Looking for a neurology specialist in Du Bois?
Compare neurologists in the Du Bois area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
5
Per 100K population
6.3
County median income
$60,181
Nearest hospital
PENN HIGHLANDS DUBOIS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ignatius is a clinical cardiology specialist, with above-average Medicare volume (top 21% in PA), with speaking/promotional industry engagement in the top 5% of PA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ignatius experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ignatius performed 346 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ignatius receive payments from pharmaceutical companies?
Yes. Dr. Ignatius received a total of $220,933 from 60 companies across 1,634 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ignatius's costs compare to other neurologists in Du Bois?
Dr. Ignatius's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ignatius) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →